NEUCA S.A. (WSE: NEU)
Health Care · Health Care Providers & Services · PL
zł703.00
-0.57% today · -2.1% 1Y
NEUCA S.A. (WSE: NEU) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $816.16M and employs 5,004 people.
Over the last twelve months the share price has lost 2.1%, trading between 627.00 and 857.00.
Tweenvest scores NEUCA S.A. across four factors: quality 76/100, value 78/100, growth 58/100, dividend 49/100. Its strongest factor is value.
NEU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $816.16M
- Revenue (TTM)
- $3.76B
- P/E
- 16.53
- EPS
- 42.76
- Dividend yield
- 2.52%
- Beta (5Y)
- 0.46
- 52-week high
- zł857.00
- 52-week low
- zł627.00
- Avg volume (3M)
- —
- Shares outstanding
- 4.52M
- Employees
- 5,004
- Next earnings
- —
About NEUCA S.A.
NEUCA S.A., headquartered in Torun, Poland, specializes in supplying pharmaceutical products to pharmacies and healthcare facilities throughout the country. The firm structures its business around distinct segments: wholesale pharmaceutical distribution, the development and marketing of proprietary drug brands, and a comprehensive healthcare services division. This healthcare arm specifically encompasses outpatient care, clinical trials, and telemedicine. Beyond these core areas, NEUCA S.A. provides an extensive array of additional services, including marketing and advertising support, agency functions, financial solutions, logistics through road cargo transport, accounting and bookkeeping, software development, information technology support, and specialized services for hospitals. The company also offers various insurance products—covering health, property, and other personal lines—and operates its own network of medical supply stores. Established in 1990 as Torfarm SA, the company rebranded to NEUCA S.A. in April 2010.
- ISIN
- PLTRFRM00018
- Founded
- 1990
- Listed since
- Nov 22, 2004
- Exchange
- Warsaw Stock Exchange
- Currency
- PLN
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hapvida Participações e Investimentos S.A.BOVESPA: HAPV3 | $847.84M | R$8.89 | +0.79% |
| HPGC Renmintongtai Pharmaceutical CorporationSHSE: 600829 | $824.19M | CN¥9.52 | +0.95% |
| Thyrocare Technologies LimitedBSE: 539871 | $820.66M | Rs499.00 | -6.62% |
| Cowealth Medical China Co.,Ltd.SHSE: 603122 | $817.73M | CN¥13.76 | -0.72% |
| AdaptHealth Corp.NasdaqCM: AHCO | $808.46M | $6.14 | +1.24% |
| Jinxin Fertility Group LimitedSEHK: 1951 | $763.54M | HK$2.29 | +6.51% |
| Entero Healthcare Solutions LimitedNSEI: ENTERO | $753.80M | Rs1,676.20 | -0.27% |
| Hygeia Healthcare Holdings Co., LimitedSEHK: 6078 | $743.20M | HK$9.61 | +1.26% |
Figures last refreshed Oct 11, 2026.